DAPA-HF study: Are the benefits uniform across non-diabetic subgroups

Indian Heart J. 2020 Sep-Oct;72(5):469-470. doi: 10.1016/j.ihj.2020.08.012. Epub 2020 Aug 19.
No abstract available

Keywords: Diabetes; Heart failure; Pre-diabetes; SGLT2 inhibitors.

Publication types

  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Disease Progression
  • Heart Failure / complications*
  • Heart Failure / drug therapy
  • Heart Failure / physiopathology
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
  • Stroke Volume / physiology*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors